SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-003224
Filing Date
2022-03-10
Accepted
2022-03-10 08:15:36
Documents
14
Period of Report
2022-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgtx-20220310x8k.htm   iXBRL 8-K 38883
2 EX-99.1 mgtx-20220310xex99d1.htm EX-99.1 189089
3 GRAPHIC mgtx-20220310xex99d1001.jpg GRAPHIC 6415
  Complete submission text file 0001558370-22-003224.txt   377095

Data Files

Seq Description Document Type Size
4 EX-101.SCH mgtx-20220310.xsd EX-101.SCH 3142
5 EX-101.LAB mgtx-20220310_lab.xml EX-101.LAB 16585
6 EX-101.PRE mgtx-20220310_pre.xml EX-101.PRE 10453
8 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20220310x8k_htm.xml XML 5045
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38520 | Film No.: 22727501
SIC: 2836 Biological Products, (No Diagnostic Substances)